Michael Lind
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Cancer Research top 5%
Papers in
- Oncology 42
- Lung Cancer Research Studies 13
- Cancer Treatment and Pharmacology 7
-
- Lung Cancer Treatments and Mutations 12
- Occupational and environmental lung diseases 8
- Co-authors
- Lynn Cawkwell (33 shared papers)Philip J Drew (14 shared papers)Laura Smith (8 shared papers)Lawrence Kevin Duffy (1 shared paper)Hideyo Inouye (1 shared paper)Dennis J. Selkoe (1 shared paper)Daniel A. Kirschner (1 shared paper)Alison J. Sinclair (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (11 papers)European Journal of Cancer (9 papers)Lung Cancer (5 papers)Annals of Oncology (5 papers)British Journal of Cancer (5 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Michael Lind
109 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 134
- Oncology 1.0k
- Cancer Research 372
- Pathology and Forensic Medicine 447
- Geriatrics and Gerontology 72
- Pulmonary and Respiratory Medicine 642
Countries citing papers authored by Michael Lind
This map shows the geographic impact of Michael Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lind more than expected).
Fields of papers citing papers by Michael Lind
This network shows the impact of papers produced by Michael Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lind. The network helps show where Michael Lind may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Lind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 435 | |
| 2 | 2006 | 200 | |
| 3 | 1981 | 168 | |
| 4 | 2013 | 164 | |
| 5 | 2016 | 164 | |
| 6 | 2006 | 163 | |
| 7 | 2004 | 122 | |
| 8 | 2004 | 117 | |
| 9 | 1988 | 112 | |
| 10 | 1994 | 109 | |
| 11 | A phase I and pharmacokinetic study of LY231514, the multitargeted antifolate. | 1998 | 82 |
| 12 | 1989 | 76 | |
| 13 | 1990 | 67 | |
| 14 | 1989 | 65 | |
| 15 | 1989 | 63 | |
| 16 | 2001 | 59 | |
| 17 | 2020 | 53 | |
| 18 | 1990 | 52 | |
| 19 | 1989 | 51 | |
| 20 | 2007 | 51 |
About Michael Lind
Michael Lind is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Molecular Biology, having authored 116 papers that have together received 4.0k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (13 papers), Chemotherapy-induced organ toxicity mitigation (13 papers), Lung Cancer Treatments and Mutations (12 papers), Cancer therapeutics and mechanisms (9 papers), Occupational and environmental lung diseases (8 papers), Cancer Treatment and Pharmacology (7 papers), Neuroendocrine Tumor Research Advances (7 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (372 citations), Pathology and Forensic Medicine (447 citations), Geriatrics and Gerontology (72 citations) and Pulmonary and Respiratory Medicine (642 citations). Michael Lind has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Lynn Cawkwell, Philip J Drew, Laura Smith, Lawrence Kevin Duffy, Hideyo Inouye, Dennis J. Selkoe, Daniel A. Kirschner, Alison J. Sinclair, Mark B. Watson and Sara Louise O’Kane. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, European Journal of Cancer, Lung Cancer, Annals of Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.